Dentsply Sirona (XRAY) and Zephyr Sleep Technologies have entered into a strategic partnership for the treatment of OSA (obstructive sleep apnea).
In August 2017, Dentsply Sirona (XRAY) launched its Cerec Zirconia Meso Block for creating customized screw-retained crowns.
Amazon (AMZN) is reportedly in talks with some of the mid-market pharmacy benefit managers. It’s looking to pursue a mail-order pharmacy.
As we’ve discussed in this series, Walgreens received FTC (Federal Trade Commission) approval to acquire 1,932 Rite Aid store on September 19.
The stock price for Rite Aid (RAD) plunged more than 12% after the announcement of the deal closure with Walgreens on September 19.
On September 19, Walgreens Boots Alliance (WBA) finally received FTC (Federal Trade Commission) approval for its long-awaited transaction with Rite Aid Corporation (RAD).
The merger between Monsanto (MON) and Bayer is worth $66 billion. It’s one of the largest deals in the agribusiness (MOO) industry.
This week, Bayer stated that it expects the Monsanto (MON) acquisition to be delayed. Bayer asked for an extension to January 22.
Almost a year ago, Bayer announced that it signed a merger agreement with Monsanto (MON) for $66 billion or $128 per Monsanto share.
Omaha-headquartered Union Pacific (UNP) operates in 23 states across the western United States. The company’s southern region is based in Houston, also a prominent freight rail hub for the railroad…
There have been varied estimates of the damages caused by Harvey, from $65.0 billion to as high as $190.0 billion. In this series, we’ll look at how Hurricanes Harvey and Irma affected Class I railroads.
According to Bloomberg, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have moved toward closing their long-awaited acquisition deal.
On September 14, 2017, Abbott Laboratories (ABT) announced its 375th consecutive quarterly dividend to be paid on November 15, 2017.
Becton Dickinson (BDX), or BD, acquired the global safety products portfolio through the acquisition of CareFusion in 2015.
On July 25, 2017, Becton Dickinson (BDX) announced the payment of quarterly dividends of $0.73 per share for 4Q17.
Becton, Dickinson and Company (BDX) closed at $196.62 on September 13, 2017.
Becton Dickinson accelerated its strategy to establish itself as the leader in single cell genomics with its recent launch of BD Rhapsody, a single cell analysis platform.
On September 13, 2017, Abbott Laboratories (ABT) announced the reimbursement approval of its Freestyle Libre system.
It didn’t take long after Apple launched its new flagship iPhone X for some top US wireless carriers to signal a return to the brutal iPhone price war we saw last year.
Apple’s flagship iPhones X won’t be available on the market until November—a stark departure from the company’s typical schedule.